Biotechnology

Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and

Iterative Health to Present AI Advancements at ECCO 2025, Highlighting Pote

Velsera Drives Momentum in 2024 with Key Platform Advancements and Strategi

Incyte and Genesis Therapeutics Announce Strategic AI-focused Research Coll

Guardant Health Reports Fourth Quarter and Full Year 2024 Financial Results

Allurion Announces Closing of Offering and Concurrent Private Placement to

VSee Health Secures $560K Contract to Deploy Virtual Command Center for Maj

BioTech Breakthrough Awards BostonGene With “Cancer Immunology Solution o

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Zoetis to Participate in Upcoming Investor Conferences

Vector Laboratories Announces Partnership With British Biotech Innovator Et

Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Fo

Eikon Therapeutics Announces Nature Methods Publication Highlighting its Pi

Veracyte to Participate in Upcoming Investor Conferences

Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with

Arima Genomics Expands Executive Team With Three Strategic Hires to Advance

Compliance Group Joins Veeva Services Partner Program to Deliver Implementa

Advancing Data Centric AI in Healthcare and Life Sciences - Elucidata Onboa

Butterfly Network to Report Fourth Quarter and Full Year 2024 Financial Res

Quantum-Si’s Customers and Researchers to Showcase Next-Generation Protei

National Compensation Guide Offers Strategic Insights for Bio-Economy Emplo